Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Xperience™ versus dilute povidone-iodine to prevent infections after implant-based breast reconstruction

Official title: A Randomized Control Trial Evaluating the Efficacy of Xperience™ Surgical Irrigation Solution Versus Dilute Povidone-Iodine in Preventing Surgical Site Infections and Improving Postoperative Outcomes in Implant-Based Breast Reconstruction

Run by University of North Carolina, Chapel Hill · NCT06649890 · Data updated 2026-11-12

This trial will test whether Xperience™ surgical irrigation reduces infection and complication rates compared with dilute povidone-iodine in women 18 and older having implant-based breast reconstruction after mastectomy.

More Surgical Site Infection trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment224 (estimated)
SponsorUniversity of North Carolina, Chapel Hill
Academic / other
Locations1 site (Chapel Hill, North Carolina)
StatusRecruiting
StartedJune 30, 2025
Main results expectedJune 30, 2028
Study endsJune 30, 2028
Registry record updatedAugust 7, 2025
Trial IDNCT06649890 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult women (18+) planning bilateral/double mastectomy followed by implant-based reconstruction (immediate, delayed, or second-stage exchange) who can attend follow-up visits at UNC Chapel Hill are ideal candidates.

Probably not a fit

Patients undergoing unilateral mastectomy, autologous reconstruction, those with known sensitivity to solution components, or those unable to complete follow-up (including expanders placed outside the UNC system) are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized interventional study assigns participants to receive either Xperience™ advanced surgical irrigation or a standard dilute povidone-iodine solution during implant-based breast reconstruction. The team will track surgical site infections, premature implant removals due to infection, and other postoperative complications, while monitoring safety outcomes. Eligible participants include adults undergoing bilateral/double mastectomy with immediate, delayed, or second-stage tissue expander/implant reconstruction at the UNC Chapel Hill system. Follow-up visits at the study site will be used to collect outcome and safety data.

Why it matters

Potential benefit: If successful, Xperience™ could lower surgical site infections and reduce the need for premature implant removal, improving recovery and outcomes after reconstruction.

How similar studies have gone: Povidone-iodine irrigation has been used with mixed results in prior work, and dedicated commercial irrigation solutions like Xperience™ are less well-studied, making this approach relatively novel in this specific setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Older than 18 years old
* Willing to comply with all study-related procedures
* Available for the duration of the study
* Participants undergoing double mastectomy surgery followed by one of the following: (1) Immediate reconstruction with tissue expander placement, (2) Delayed reconstruction with tissue expander or implant placement, (3) Immediate reconstruction with implant placement, (4) Second-stage reconstruction with tissue expander to implant exchange

Exclusion Criteria:

* Participants unable to participate in follow-up visits
* Participants undergoing unilateral mastectomy
* Tissue expanders placed by a surgeon outside of the UNC Chapel Hill Hospital System
* Undergoing autologous reconstruction
* Participant is unable to provide signed and dated informed consent
* Unwilling or unable to comply with all study-related procedures.
* Known history of sensitivity or allergic reaction to any of the components of the Xperience™ irrigation solution or dilute povidone-iodine irrigation
* Participant with any conditions that would be a contraindication to receiving surgery such as contraindications to general anesthesia
* Pregnant, planning to become pregnant or breast feeding participants
* Individuals providing informed consent with any mental impairment or condition that would make them unable to properly consent without use of legally authorized representative (LAR) or additional participant protections.
* Incarcerated participants

Where it's running

  • University of North Carolina at Chapel Hill Hospital
    Chapel Hill, North Carolina, United States
    Recruiting

Study contacts

  • Principal investigator: Adeyemi Ogunleye, MD — University of North Carolina, Chapel Hill
  • Study coordinator: Adeyemi Ogunleye, MD
  • Email: yemi@med.unc.edu
  • Phone: (919) 966-4446

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.